Thermo Fisher Scientific Q3 2026 Results Raise Valuation Questions

October 29, 2026 - 13:40

Thermo Fisher Scientific (TMO) released third quarter 2026 results that showed sales of US$12.1b and net income of US$1.7b. These figures frame how the stock's recent move might be interpreted.

Thermo Fisher Scientific shares have been building momentum, with a 22.1% 90 day share price return and 18.8% year to date, alongside a 26.6% one year total shareholder return that points to investors becoming more comfortable with the risk and earnings profile.

The question now is whether the market has already absorbed the good news embedded in those numbers. A 22.1% run over three months is a strong move for a company of this size, and it suggests expectations have risen in step with the share price. When sales and net income land roughly in line with what the market anticipated, a stock that has already climbed can stall, because the results confirm the story rather than add a new chapter to it.

Investors weighing the stock have to decide whether the current price reflects the earnings power shown in the quarter or whether there is room for further re-rating. The year to date gain of 18.8% and the one year total shareholder return of 26.6% both point to a stock that has rewarded holders, but they also raise the bar for future performance. Any softness in coming quarters would be measured against a much higher base.

For now, the third quarter numbers give a clear snapshot of the business: US$12.1b in sales and US$1.7b in net income. How the market treats those figures in the sessions ahead will say a lot about whether Thermo Fisher Scientific is fully priced or still has room to run.